Quantitative motor assessment in myotonic dystrophy

Canadian Journal of Neurological Sciences

Volumn 30, Issue 2, 2003, Pages 129-136

  Mathieu, Jean ^a,b   Boivin, H ^a   Richards, C L ^c  

^a Centre de readaptation en deficience physique Jonquiere   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; DISEASE DURATION; FEMALE; HAND GRIP; HIP; HUMAN; LINEAR REGRESSION ANALYSIS; MALE; MANUAL MUSCLE TESTING; MOTOR PERFORMANCE; MUSCLE FUNCTION; MUSCLE WEAKNESS; MYOTONIC DYSTROPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; QUANTITATIVE MUSCLE TESTING; SCREENING TEST; TIMED FUNCTIONAL TESTING;

EID: 0038510954     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100053397     Document Type: Article

References (24)

1. Harley HG, Brook JD, Rundle SA, et al. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature 1992;355:545-546.
2. Harper PS. Myotonic dystrophy. 3rd ed. London: W.B.Saunders, 2001.
3. Mathieu J, DeBraekeleer M, Prévost C. Genealogical reconstruction of myotonic dystrophy in the Saguenay-Lac-Saint-Jean area (Quebec, Canada). Neurology 1990;40:839-842.
4. Brooke MH, Fenichel GM, Griggs RC, et al. Clinical investigation in Duchenne dystrophy: 2. Determination of the "power" of therapeutic trials based on the natural history. Muscle Nerve 1983;6:91-103.
5. Munsat TL, Andres PL, Finison L, Conlon T, Thibodeau L. The natural history of motoneuron loss in amyotrophic lateral sclerosis. Neurology 1988;38:409-413.
6. Andres PL, Finison L, Conlon T, Thibodeau L, Munsat TL. Use of composite scores (megascores) to measure deficit in amyotrophic lateral sclerosis. Neurology 1988;38:405-408.
7. Pradas J, Finison L, Andres PL, et al. The natural history of amyotrophic lateral sclerosis and the use of natural history controls in therapeutic trials. Neurology 1993;43:751-755.
8. Munsat TL. Issues in clinical trial design 1: use of natural history controls. A protagonist view. Neurology 1996;47:S96-S97.
9. Tawil R, McDermott MP, Mendell JR, et al. Facioscapulohumeral muscular dystrophy (FSHD): design of natural history study and results of baseline testing. Neurology 1994;44:442-446.
10. The FSH-DY Group. A prospective quantitative study of the natural history of facioscapulohumeral muscular dystrophy (FSHD): implications for therapeutic trials. Neurology 1997;48:38-46.
11. Mathieu J, Boivin H, Meunier D, Gaudreault M, Bégin P. Assessment of a disease-specific impairment rating scale in myotonic dystrophy. Neurology 2001;56(3):336-340.
12. Koch MC, Grimm T, Harley HG, Harper PS. Genetic risk for children of women with myotonic dystrophy. Am J Hum Genet 1991;48:1084-1091.
13. Appel V, Stewart SS, Smith G, Appel SH. A rating scale for amyotrophic lateral sclerosis: description and preliminary experience. Ann Neurol 1987;22:328-333.
14. Fisher LD, Van Belle G. Biostatistics. A methodology for the Health Sciences. John Wiley and Sons, New York, 1993.
15. SPSS Advanced and Professional Statistics 6.1., Chicago, IL. SPSS Inc., 1994.
16. Moxley RT. Functional testing. Muscle Nerve 1990 (Suppl):S26-S29.
17. Mendell JR, Florence J. Manual muscle testing. Muscle Nerve 1990 (Suppl):S16-S20.
18. Personius KE, Pandya S, King WM, Tawil R, McDermott MP and the FSH DY Group. Facioscapulohumeral dystrophy natural history study: standardization of testing procedures and reliability of measurements. Phys Ther 1994;74:253-263.
19. Johnson ER, Abresch RT, Carter GT, et al. Profile of neuromuscular diseases: myotonic dystrophy. Am J Phys Rehabil 1995;74(Suppl 5):S104-S116.
20. FSH-DY Group. A prospective, quantitative study of the natural history of facioscapulohumeral muscular dystrophy (FSHD): implications for therapeutic trials. Neurology 1997;48:38-46.
21. Andres PL, Hedlund W, Finison L, et al. Quantitative motor assessment in amyotrophic lateral sclerosis. Neurology 1986;36:937-941.
22. Griggs RC, Pandya S, Florence JM et al. Randomized controlled trial of testosterone in myotonic dystrophy. Neurology 1989;39: 219-222.
23. Lindeman E, Leffers P, Reulen J, Spaans F, Drukker J. Quadriceps strength and timed motor performances in myotonic dystrophy, Charcot-Marie-Tooth disease, and healthy subjects. Clin Rehabil 1998;12:127-135.
24. Orndahl G, Grimby G, Grimby A, Johansson G, Wilhelmsen L. Functional deterioration and selenium-vitamin E treatment in myotonic dystrophy. A placebo-controlled study. J Intern Med 1994;235:205-210.